The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correction to The Heart Outcomes Prevention Evaluation Study Investigators, N Engl J Med 342(3):145-153 January 20, 2000.

Correction
PreviousPrevious
Volume 342:748 March 9, 2000 Number 10

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by The Heart Outcomes Prevention Evaluation Study Investigators
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients . On page 145, in line 16 of the Results paragraph of the Abstract, the relative risk of cardiac arrest should have been 0.62; P = 0.02, not 0.63;P = 0.03, as printed. On page 151, the sentence that begins four lines from the bottom of the left-hand column should have read, "We also observed a reduction in the incidence of heart failure in patients with no evidence of impairment of left ventricular systolic function," not "left ventricular systolic dysfunction," as printed. On page 152, in . . . [Full Text of this Article]


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.